Table 3

Stratification analysis of risk of major adverse cardiovascular events among different group in the model 1 matched population

Any HZ vaccineNo HZ vaccine
nNo. of eventnNo. of eventHR (95% CI)
Age
50–6528 258163428 25819680.80 (0.75 to 0.86)
>6516 903185916 90317230.83 (0.78 to 0.89)
Sex
Female22 591155922 59118080.77 (0.72 to 0.83)
Male20 603166520 60319950.74 (0.69 to 0.79)
Type 1 diabetes23010230160.25 (0.08 to 0.75)
Type 2 diabetes42 503294542 50335880.71 (0.68 to 0.75)
  • If the patient’s count is 1–10, the results indicate a count of 10.

  • Model 1 indicates any HZ vaccination versus no HZ vaccination population.

  • Any vaccine, Shingrix or Zostavax; HZ, herpes zoster.